期刊文献+

免疫相关性眼病的免疫学治疗进展 被引量:4

Research progress on immunologic therapy of immune associated ophthalmopathy
下载PDF
导出
摘要 免疫相关性眼病是影响青壮年视力健康的主要疾病之一,包括眼部肿瘤、葡萄膜炎、角膜移植排斥反应、甲状腺相关性眼病等。这些疾病治疗困难,预后差,是眼科临床工作中亟待解决的问题。免疫治疗正在成为眼病综合治疗中的一种重要方法。 Immune associated ophthalmopathy ranks as one of the major causes of visual handicap in adults, including ocular tumor, uveitis, corneal transplantation rejection, thyroid associated ophthalmopathy, and so on.These conditions are difficult to therapy, bad prognosis, and are an urgent ophthalmic clinical problems to be solved. Immunotherapies have been playing an important role in the comprehensive therapy for immune associated ophthalmopathy. This article reviewed on this study.
出处 《国际眼科杂志》 CAS 北大核心 2018年第2期263-266,共4页 International Eye Science
关键词 免疫治疗 恶性黑色素瘤 葡萄膜炎 角膜移植 甲状腺相关眼病 immunologic therapy malignant melanoma uveitis corneal transplantation thyroid associated ophthalmopathy
  • 相关文献

参考文献3

二级参考文献36

  • 1Mourits MP,Prummel MF,Wiersinga WM,et al.Clinical activity score as a guide in the management of patients with Graves′ ophthalmopathy[J].Clin Endocrinol(Oxf),1997,47(1): 9-14.
  • 2Van Dyk HJ.Orbital Graves′ Disease: A Modification of the “NO SPEC-S” Classification[J].Ophthalmology,1981,88(6): 479-483.
  • 3Jameson JL,De Groot LJ.Endocinology,adult and pediatric.6th edition,volume Ⅱ[J].Phladelphia: Elsevier Health Sciences,2010,2010: 1565-1568.
  • 4Khanna D,Chong KK,Afifiyan NF,et al.Rituximab treatment of patients with severe,corticosteroid-resistant thyroid-associated ophthalmopathy[J].Ophthalmology,2010,117(1): 133-139.
  • 5Stamato FJ,Maciel RM,Manso PG,et al.Colchicine in the treatment of the inflammatory phase of Graves′ ophthalmopathy: a prospective and randomized trial with prednisone[J].Arq Bras Oftalmol,2006,69(6): 811-816.
  • 6Cs B,Korányi K.Primary prevention of thyroid associated ophthalmopathy by pentoxifylline[J].J Addict Res Ther,2011,2(118): 2.
  • 7Moura J,Mimura LY,Bloise W.Treatment of Severe Graves Ophthalmopathy with a PPAR-{gamma} Antagonist and Cylooxygenase-2 Inhibitor[J].Endocr Rev,2012,33.
  • 8Marcocci C,Kahaly GJ,Krassas GE,et al.Selenium and the course of mild Graves′ orbitopathy[J].New England J Med,2011,364(20): 1920-1931.
  • 9Iaccarino L,Rampudda M,Canova M,et al.Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?[J] Autoimmun Rev,2007,6(3): 190-195.
  • 10Hassan A,Waller S.Single centre retrospective study of the safety and efficacy of mycophenolate mofetil (MMF) in children and adolescents with nephrotic syndrome[J].Archives of Disease in Childhood,2012,97(Suppl 1): A162.

共引文献55

同被引文献32

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部